Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin supplementation as an adjuvant therapy in neonatal respiratory distress syndrome
TCTR20200326001Phase 1Active, not recruiting
- Sponsor
- mohamed shawky elfarargy
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of melatonin in respiratory distress syndrome (RDS), sponsored by mohamed shawky elfarargy. Started Jun 2016; status: active, not recruiting.
02
Drugs
melatonin
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on TCTR20200326001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200326001.